Home » Cancer Topics » Pediatric Cancer
Pediatric Cancer
FEATURED CONTENT
The study showed that tumor sequencing could identify actionable genetic alterations, which could then be used to assign patients to trials of molecularly targeted therapies.
Children prescribed a medication containing a phthalate had a 19% higher risk of developing any childhood cancer.
Cesarean was associated with increased risk of any cancer, hematopoietic cancers, and solid tumors.
Sixty-nine percent of patients had at least 1 genetic alteration leading to a targeted treatment suggestion.
There is a greater than 2-fold increased risk of cancer among patients with pediatric-onset inflammatory bowel disease.
PEDIATRIC CANCER NEWS Load More
Open
Next post in Pediatric Cancer
Close
Close more info about Early Molecular Testing May Benefit Young Patients With Refractory Cancers
Loading...
Close more info about Early Molecular Testing May Benefit Young Patients With Refractory Cancers
Loading...